scholarly article | Q13442814 |
P356 | DOI | 10.2147/NSS.S71838 |
P8608 | Fatcat ID | release_eeresitbpvgvhddisci7jmus44 |
P3181 | OpenCitations bibliographic resource ID | 4299800 |
P932 | PMC publication ID | 4319556 |
P698 | PubMed publication ID | 25678831 |
P2093 | author name string | Thomas Roth | |
Nava Zisapel | |||
Tali Nir | |||
P2860 | cites work | Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety | Q21245261 |
Prolonged-release formulation of melatonin (Circadin) for the treatment of insomnia | Q22306021 | ||
Beta 1-adrenergic antagonists and melatonin reset the clock and restore sleep in a circadian disorder, Smith-Magenis syndrome | Q22306504 | ||
How to trick mother nature into letting you fly around or stay up all night | Q23923291 | ||
Short-wavelength light sensitivity of circadian, pupillary, and visual awareness in humans lacking an outer retina | Q24684932 | ||
Stability, precision, and near-24-hour period of the human circadian pacemaker | Q28138096 | ||
Suppression of melatonin secretion in some blind patients by exposure to bright light | Q28242632 | ||
Human phase response curves to three days of daily melatonin: 0.5 mg versus 3.0 mg | Q28382973 | ||
Nocturnal melatonin onset is phase locked to the primary sleep gate. | Q53967255 | ||
Light suppresses melatonin secretion in humans | Q54294567 | ||
Relationship between Napping and Melatonin in the Blind | Q61055166 | ||
The human phase response curve (PRC) to melatonin is about 12 hours out of phase with the PRC to light | Q74287351 | ||
Is there an intrinsic period of the circadian clock? | Q95787724 | ||
The dim light melatonin onset, melatonin assays and biological rhythm research in humans | Q33543309 | ||
Melatonin in circadian sleep disorders in the blind. | Q33543314 | ||
Entrainment of free-running circadian rhythms by melatonin in blind people | Q33921061 | ||
Larger phase angle between sleep propensity and melatonin rhythms in sighted humans with non-24-hour sleep-wake syndrome. | Q34113213 | ||
Different types of melatonin circadian secretory rhythms in some blind subjects | Q34271484 | ||
The effects of low-dose 0.5-mg melatonin on the free-running circadian rhythms of blind subjects. | Q34272772 | ||
Circadian rhythm sleep disorders: pathophysiology and potential approaches to management | Q34313513 | ||
Melatonin stabilises sleep onset time in a blind man without entrainment of cortisol or temperature rhythms | Q34351384 | ||
Melatonin as a chronobiotic. | Q34384226 | ||
How to read a paper. Statistics for the non-statistician. II: "Significant" relations and their pitfalls | Q34437356 | ||
Circadian rhythm sleep disorders: lessons from the blind | Q35046580 | ||
Melatonin role in experimental arthritis | Q35698714 | ||
Tasimelteon: first global approval | Q38194529 | ||
Statistical and clinical significance, and how to use confidence intervals to help interpret both | Q39888306 | ||
Circadian rhythms: basic neurobiology and clinical applications | Q41360588 | ||
Melatonin treatment for eastward and westward travel preparation | Q43219782 | ||
Sleep/wake cycles in the dark: sleep recorded by polysomnography in 26 totally blind subjects compared to controls | Q44154819 | ||
Photic resetting of the human circadian pacemaker in the absence of conscious vision | Q44238206 | ||
Melatonin phase-shifts human circadian rhythms with no evidence of changes in the duration of endogenous melatonin secretion or the 24-hour production of reproductive hormones | Q44582508 | ||
Melatonin acutely improves the neuroendocrine architecture of sleep in blind individuals | Q44645551 | ||
Eventual entrainment of the human circadian pacemaker by melatonin is independent of the circadian phase of treatment initiation: clinical implications | Q44765058 | ||
Timing light treatment for eastward and westward travel preparation | Q44883866 | ||
Melatonin and zopiclone as facilitators of early circadian sleep in operational air transport crews. | Q44902784 | ||
Melatonin advances the circadian timing of EEG sleep and directly facilitates sleep without altering its duration in extended sleep opportunities in humans | Q45086588 | ||
Sleep-facilitating effect of exogenous melatonin in healthy young men and women is circadian-phase dependent | Q48497328 | ||
The circadian body temperature rhythm in the elderly: effect of single daily melatonin dosing | Q48498315 | ||
Sleep and activity rhythms are related to circadian phase in the blind. | Q48748816 | ||
Disturbance of sleep in blindness | Q48783990 | ||
Association of sleep-wake habits in older people with changes in output of circadian pacemaker | Q48882717 | ||
Melatonin rhythms in night shift workers | Q48883129 | ||
Melatonin Administration to Blind People: Phase Advances and Entrainment | Q48914251 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | melatonin | Q180912 |
placebo | Q269829 | ||
multicenter clinical trial | Q6934595 | ||
sleep | Q35831 | ||
P304 | page(s) | 13-23 | |
P577 | publication date | 2015-01-01 | |
P1433 | published in | Nature and Science of Sleep | Q15817879 |
P1476 | title | Prolonged release melatonin for improving sleep in totally blind subjects: a pilot placebo-controlled multicenter trial | |
P478 | volume | 7 |
Q28074572 | Comparative Review of Approved Melatonin Agonists for the Treatment of Circadian Rhythm Sleep-Wake Disorders |
Q60304311 | Long-Term Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children with Autism Spectrum Disorder |
Q28083929 | MT1 and MT2 Melatonin Receptors: A Therapeutic Perspective |
Q92404206 | Melatonin: Countering Chaotic Time Cues |
Q47557441 | New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation |
Q47349614 | Non-24-Hour Sleep–Wake Rhythm Disorder in the Totally Blind: Diagnosis and Management. |
Q64119035 | Prolonged-release melatonin in patients with idiopathic REM sleep behavior disorder |
Q91784560 | Sleep-Wake Disturbance Related to Ocular Disease: A Systematic Review of Phase-Shifting Pharmaceutical Therapies |
Q52641607 | Synthetic pathways and processes for effective production of 5-hydroxytryptophan and serotonin from glucose in Escherichia coli. |
Q37151830 | The Efficacy of Oral Melatonin in Improving Sleep in Cancer Patients with Insomnia: A Randomized Double-Blind Placebo-Controlled Study |
Q90257027 | The Risk of Night Shift Workers to the Glucose Blood Levels, Saliva, and Dental Caries |
Search more.